🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

23+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 20 of 23 recruiting trials for “acth-dependent-cushing-syndrome

NARecruitingNCT04569591

DDAVP for Pituitary Adenoma

👨‍⚕️ Prashant Chittiboina, M.D., National Institute of Neurological Disorders and Stroke (NINDS)📍 1 site📅 Started Mar 2026View details ↗
NAEnrolling by InvitationNCT07108244

Use of [18F]FET PET-MRI to Improve Detection of Pituitary Adenomas in Cushing's Disease

🏥 University Hospital, Basel, Switzerland📍 2 sites📅 Started Oct 2025View details ↗
RecruitingNCT07168122

Establishment and Clinical Application of Reference Intervals of Salivary Cortisol

🏥 Shanghai 6th People's Hospital📍 1 site📅 Started Sep 2025View details ↗
Phase 2RecruitingNCT05971758

Fimepinostat, Combination HDAC and Pi3-kinase Inhibitor Tumor-Directed Therapy for Cushing Disease

🏥 University of California, Los Angeles📍 1 site📅 Started Jan 2025View details ↗
Phase 2RecruitingNCT06635629

Desmopressin Stimulation Test Performance in ACTH-Dependent Cushing Syndrome

👨‍⚕️ Lynnette K Nieman, M.D., National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)📍 1 site📅 Started Dec 2024View details ↗
RecruitingNCT07335315

Evaluation of Intraoperative Contrast Enhanced Ultrasound for the Identification of Pituitary Adenoma in Cushing's Disease Compared to Other Pituitary Tumors

👨‍⚕️ Ian Mark, MD, Mayo Clinic📍 1 site📅 Started Jun 2024View details ↗
NARecruitingNCT06250699

A Single Center Randomized Controlled Study on the Promotion of Rapid Recovery

👨‍⚕️ meng zhe, Wuhan University📍 1 site📅 Started Jan 2024View details ↗
RecruitingNCT07463625

Evaluation of Positron Emission Tomography (PET) With [18F]FET for the Detection of ACTH-Secreting Corticotroph Pituitary Neuroendocrine Tumors.

🏥 Hospices Civils de Lyon📍 1 site📅 Started Nov 2023View details ↗
NARecruitingNCT05911620

Evaluation of the Severity of Hepatic Fibrosis by Magnetic Resonance Elastography in the Diagnosis of Endogenous Hypercorticism

🏥 Central Hospital, Nancy, France📍 1 site📅 Started Oct 2023View details ↗
Phase 1, PHASE2RecruitingNCT05804669

A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome

🏥 Crinetics Pharmaceuticals Inc.📍 1 site📅 Started Oct 2023View details ↗
NARecruitingNCT05881005

NAC- NAFLD and Cushing

👨‍⚕️ Claire BRIET, University Hospital of Anger📍 6 sites📅 Started Sep 2023View details ↗
RecruitingNCT06050057

Surgical Treatment of Adrenal Diseases- Laparoscopic vs. Robotic-assisted Adrenalectomy

👨‍⚕️ MUDr. Igor Hartmann Ph.D., Dpt. of Urology, University hospital Olomouc📍 1 site📅 Started Sep 2023View details ↗
RecruitingNCT05521529

Cushing's Syndrome Before and After Treatment (CORRECT)

👨‍⚕️ Jens Otto Lunde Jørgensen, Professor, AARHUS UNIVERSITY HOSPITAL, Medical Research Laboratory📍 1 site📅 Started Feb 2023View details ↗
RecruitingNCT06962202

Modified Desmopressin (mDesmo) Using Cold-Kit for PET/CT

🏥 Post Graduate Institute of Medical Education and Research, Chandigarh📍 1 site📅 Started Aug 2022View details ↗
RecruitingNCT04890444

China Adrenal Disease Registry

🏥 Shanghai Jiao Tong University School of Medicine📍 1 site📅 Started Jun 2021View details ↗
Phase 2RecruitingNCT03708900

Pharmacokinetic (PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's Syndrome

👨‍⚕️ Recordati AG, Recordati AG📍 15 sites📅 Started Apr 2021View details ↗
Phase 4RecruitingNCT06801249

Effect of Metyrapone on Cardiovascular Risk Factors in Patients With Adrenal Incidentalomas and Cushing's Syndrome

👨‍⚕️ Guido Di Dalmazi, MD, IRCCS Azienda Ospedaliero-Universitaria di Bologna📍 3 sites📅 Started Feb 2021View details ↗
RecruitingNCT04543253

Recovery From Cushing Syndrome and Mild Autonomous Cortisol Secretion (MACS)

👨‍⚕️ Irina Bancos, MD, MS, Mayo Clinic📍 1 site📅 Started Jul 2019View details ↗
RecruitingNCT03831958

Long-Term Follow-Up of Survivors of Pediatric Cushing Disease

👨‍⚕️ Deborah P Merke, M.D., Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)📍 1 site📅 Started Mar 2019View details ↗
Phase 2RecruitingNCT03774446

Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease

👨‍⚕️ Shlomo Melmed, MD, Cedars-Sinai Medical Center📍 1 site📅 Started Nov 2018View details ↗
Page 1 of 2Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →